ADVERTISEMENTs
US FDA approves updated COVID shots ahead of fall season
The vaccines were approved to control the spread of a variant known as "KP.2", which dominated infections in recent months.
FILE PHOTO: Vials with a sticker reading, "COVID-19 / Coronavirus vaccine / Injection only" and a medical syringe are seen in front of a displayed Pfizer logo in this illustration taken October 31, 2020. / REUTERS/Dado Ruvic/File Photo
The U.S. Food and Drug Administration has approved updated COVID-19 vaccines made by Pfizer and Moderna targeting newer variants of the disease in time for a fall vaccination campaign, the agency said on Aug.22.
The U.S. health regulator has approved the vaccines to target a variant known as "KP.2", which dominated infections in recent months. It had asked manufacturers in June to target the strain.
"Vaccination continues to be the cornerstone of COVID-19 prevention," said Peter Marks, director of the FDA's Center for Biologics Evaluation and Research.
The FDA granted emergency use authorization for Moderna's shot, branded as Spikevax, and Pfizer and BioNTech shot branded as Comirnaty.
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT
.jpg)
E Paper
ADVERTISEMENT
Video
.jpg)
.png)
.png)
.png)
Comments
Start the conversation
Become a member of New India Abroad to start commenting.
Sign Up Now
Already have an account? Login